Edition:
United States

Anthem Inc (ANTM.N)

ANTM.N on New York Stock Exchange

286.33USD
16 Nov 2018
Change (% chg)

$2.19 (+0.77%)
Prev Close
$284.14
Open
$284.15
Day's High
$288.94
Day's Low
$284.00
Volume
360,207
Avg. Vol
320,943
52-wk High
$290.77
52-wk Low
$215.58

Chart for

About

Anthem, Inc. is a health benefits company. The Company operates through three segments: Commercial and Specialty Business, Government Business and Other. It offers a spectrum of network-based managed care plans to large and small employer, individual, Medicaid and Medicare markets. Its managed care plans include preferred... (more)

Overall

Beta: 0.76
Market Cap(Mil.): $50,736.61
Shares Outstanding(Mil.): 262.58
Dividend: 0.70
Yield (%): 1.45

Financials

  ANTM.N Industry Sector
P/E (TTM): 18.28 23.93 33.59
EPS (TTM): 10.57 -- --
ROI: -- -0.02 15.05
ROE: 11.26 16.31 16.62

Anthem predicts better 2019 than Wall Street forecast, shares rise

Anthem Inc on Wednesday said its own expectations for 2019 earnings are ahead of current Wall Street estimates and the health insurer also raised its 2018 profit forecast, and its shares rose as much as 5 percent.

Oct 31 2018

UPDATE 3-Anthem predicts better 2019 than Wall Street forecast, shares rise

Oct 31 Anthem Inc on Wednesday said its own expectations for 2019 earnings are ahead of current Wall Street estimates and the health insurer also raised its 2018 profit forecast, and its shares rose as much as 5 percent.

Oct 31 2018

CORRECTED-UPDATE 1-Anthem quarterly profit beats estimates, raises 2018 forecast

Oct 31 Anthem Inc reported quarterly profit that topped analysts' estimates on Wednesday on lower medical costs and the No.2 U.S. health insurer raised its full-year adjusted earnings forecast.

Oct 31 2018

Takeda hikes annual profit forecast by a third after second-quarter profit jump

TOKYO Japan's Takeda Pharmaceutical Co Ltd on Wednesday boosted its annual operating profit outlook by a third after second-quarter earnings surged on strong global sales of its drugs for bowel disease and multiple myeloma.

Oct 31 2018

UPDATE 2-Takeda hikes annual profit forecast by a third after Q2 profit jump

* Boosted by strong sales of bowel disease, multiple myeloma drugs (Adds executive comments from news conference)

Oct 31 2018

Anthem reports 28.5 pct rise in quarterly profit

Oct 31 Anthem Inc reported a 28.5 percent rise in quarterly profit on Wednesday, as the U.S. health insurer reined in medical costs.

Oct 31 2018

Takeda's raises full-year outlook after Q2 profit rise

TOKYO, Oct 31 Takeda Pharmaceutical Co Ltd on Wednesday raised its annual operating profit outlook to 268.9 billion yen.

Oct 31 2018

Deals of the day-Mergers and acquisitions

Oct 29 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Monday:

Oct 29 2018

Deals of the day-Mergers and acquisitions

Oct 29 The following bids, mergers, acquisitions and disposals were reported by 1000 GMT on Monday: ** IBM Corp said on Sunday it had agreed to acquire U.S. software company Red Hat Inc for $34 billion, including debt, as it seeks to diversify its technology hardware and consulting business into higher-margin products and services. ** Australian adult education provider Navitas Ltd rebuffed a A$1.97 billion ($1.4 billion) approach from its founder and a private equity firm, leaving s

Oct 29 2018

UPDATE 1-UK Stocks-Factors to watch on Oct 29

Oct 29 - Britain's FTSE 100 index is seen opening 10 points higher at 6,949 on Monday, according to financial bookmakers, with FTSE 100 futures up 0.87 percent ahead of the cash market open.

Oct 29 2018

Earnings vs. Estimates